Additionally, based upon the acute hydrochlorothiazide reduction of arterial pressure in NCC knockout mice subjected to Na+-restricted diet and in NCC/pendrin double-knockout mice (Alshahrani et al., 2017a; above), TZD may have been predicted to reduce arterial pressure in patients with Gitelman’s syndrome. This evidence concerns the gene SLC12A3 and Gitelman syndrome.